Lina
Lina helps you use it. Track doses, log meals with AI, manage side effects and get answers.
The problem it says it solves
The GLP-1 journey is about more than just medication. Weight loss is not just physical, it is mental, emotional, and built on daily habits.
Who it says it is for
People taking Ozempic, Wegovy, Mounjaro, Zepbound, or any other GLP-1 and peptide medication.
Revenue as published
| Figure | Value | What it means |
|---|---|---|
| Revenue, last 30 days | 247 | USD received in the thirty days before the snapshot |
| Revenue, trailing 12 months | 4,853 | USD received in the twelve months before the snapshot |
| Monthly recurring revenue | 415 | The recurring part only, as the provider reports it |
Listed for sale
Asking 14,000 USD, stated at a multiple of 4.7x, with 0 offers received.
Profile
| Founded | 2026-01-01 |
| Team | 1 person |
| Funding | Bootstrapped |
| Audience | B2C |
| Payment provider | RevenueCat |
| Pricing | Free · In‑App Purchases; $39.99 per year or $5.99 per month |
Markets Health & Fitness Mobile Apps AI Productivity.